<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02062411</url>
  </required_header>
  <id_info>
    <org_study_id>2013－9－23－3</org_study_id>
    <nct_id>NCT02062411</nct_id>
  </id_info>
  <brief_title>A Randomized Controlled Study of Cognitive Behavioral Therapy for Adults With Attention Deficit Disorder</brief_title>
  <official_title>A Randomized Controlled Study of Cognitive Behavioral Therapy for Adults With Attention Deficit Disorder</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Peking University Sixth Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Peking University Sixth Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether cognitive behavioral therapy (CBT) is
      effective in the treatment of attention deficit and emotional, executive function and social
      function dysregulation due to attention deficit disorder (ADHD).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Participations will be randomly assigned to 3 groups which are CBT with booster sessions
      group, CBT only group and waiting group.With the comparison of first tow groups we will
      explore the effect of booster sessions, and the last two groups the effect of CBT programme.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2013</start_date>
  <completion_date type="Actual">March 2016</completion_date>
  <primary_completion_date type="Actual">March 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in ADHD Rating Scale</measure>
    <time_frame>Baseline, at the end of week 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, and 11 in treatment, 12 weeks (post), 24 weeks (FU6), 36 weeks (FU9), and 48 weeks (FU12)</time_frame>
    <description>ADHD symptom severity as measured by the ADHD rating scale (DuPaul, et al., 1998) a scale that ranges from 0-54 with 0 indicating lower severity.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in Conners Adult ADHD Rating Scale Self-report Screening Version (CAARS-S:SV)</measure>
    <time_frame>Baseline, at the end of week 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, and 11 in treatment, 12 weeks (post), 24 weeks (FU6), 36 weeks (FU9), and 48 weeks (FU12)</time_frame>
    <description>The CAARS-S:SV is a self-reported scale measures the ADHD symptom severity including 30 items rating from 0 to 3.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Self-Rating Anxiety Scale (SAS)</measure>
    <time_frame>Baseline, at the end of week 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, and 11 in treatment, 12 weeks (post), 24 weeks (FU6), 36 weeks (FU9), and 48 weeks (FU12)</time_frame>
    <description>The Self-Rating Anxiety Scale (SAS) with 20 items measures the level of anxiety.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Self-rating depression scale (SDS)</measure>
    <time_frame>Baseline, at the end of week 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, and 11 in treatment, 12 weeks (post), 24 weeks (FU6), 36 weeks (FU9), and 48 weeks (FU12)</time_frame>
    <description>The Self-rating depression scale (SDS) is used to measure the level of depression.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Behavior Rating Inventory of Executive Function-Adult Version (BRIEF-A)</measure>
    <time_frame>Baseline, 12 weeks (post), 24 weeks (FU6), and 48 weeks (FU12)</time_frame>
    <description>The BRIEF-A measures the impairment level of executive function in ADHD adults.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Cambridge Neuropsychological Test Automatic Battery (CANTAB)</measure>
    <time_frame>Baseline, 12 weeks (post), 24 weeks (FU6), and 48 weeks (FU12)</time_frame>
    <description>The CANTAB is a computerized neuropsychological test measuring the cognitive and executive function.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Barratt impulsiveness scale (BIS)</measure>
    <time_frame>Baseline, 12 weeks (post), 24 weeks (FU6), and 48 weeks (FU12)</time_frame>
    <description>The Barratt impulsiveness scale including 30 items is used to measure impulsiveness.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in self-esteem scale (SES)</measure>
    <time_frame>Baseline, 12 weeks (post), 24 weeks (FU6), and 48 weeks (FU12)</time_frame>
    <description>The self-esteem scale measures the level of self-esteem.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in World Health Organization Quality of Life-Brief Version (WHOQOL-BREF)</measure>
    <time_frame>Baseline, 12 weeks (post), 24 weeks (FU6), and 48 weeks (FU12)</time_frame>
    <description>The WHOQOL-BREF is the short version of World Health Organization Quality of Life scale and includes 26 items measuring the level of life quality.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Brain Oxygenation Level Dependent (BOLD) Signal</measure>
    <time_frame>Baseline, 12 weeks (post)</time_frame>
    <description>The level of BOLD activity during working memory task after CBT is compared with baseline level to explore the potential effects of CBT on brain.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">108</enrollment>
  <condition>Attention Deficit Disorder</condition>
  <arm_group>
    <arm_group_label>CBT with booster sessions</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will receive 12 cognitive-behavioral therapy sessions weekly and 3 booster sessions monthly following our protocol.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>CBT only</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants will only receive 12 cognitive-behavioral therapy sessions weekly.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>waiting</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Participations will not be treated with CBT and keep waiting for 12 weeks for comparison.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>CBT only</intervention_name>
    <description>Participants will learn 12 sessions including educational information about ADHD and skills in organization and plan, reducing distractibility, and adaptive thinking.</description>
    <arm_group_label>CBT only</arm_group_label>
    <other_name>Mastering Your Adult ADHD manual (Safren, et al., 2005)</other_name>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>CBT with booster sessions</intervention_name>
    <description>Participants are provided with the same CBT programme and additional 3 booster sessions which summarize and extend the 3 main topics of the CBT programme in order to improve the skills practice ability.</description>
    <arm_group_label>CBT with booster sessions</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Outpatients from Peking University Sixth Hospital

          -  Diagnosis of adult ADHD based on Diagnostic and statistical manual of mental
             disorders, Fourth Edition (DSM-IV)

          -  Stable on medications for adult ADHD for at least 2 months

        Exclusion Criteria:

          -  Severe major depression, clinically significant panic disorder, bipolar disorder,
             organic mental disorders, psychotic disorders, or pervasive developmental disorders

          -  Intelligence Quotient (IQ) less than 90

          -  Suicide risk

          -  Unstable physical condition

          -  Prior participation in cognitive behavioral therapy for ADHD or other psychological
             therapy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Qiujin Qian, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Peking University Sixth Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Peking University Sixth Hospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100191</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>April 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 12, 2014</study_first_submitted>
  <study_first_submitted_qc>February 12, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 13, 2014</study_first_posted>
  <last_update_submitted>April 28, 2016</last_update_submitted>
  <last_update_submitted_qc>April 28, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 29, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Peking University Sixth Hospital</investigator_affiliation>
    <investigator_full_name>Qiujin Qian</investigator_full_name>
    <investigator_title>PhD</investigator_title>
  </responsible_party>
  <keyword>attention deficit disorder (ADHD)</keyword>
  <keyword>cognitive behavioral therapy (CBT)</keyword>
  <keyword>adult</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Disease</mesh_term>
    <mesh_term>Attention Deficit Disorder with Hyperactivity</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

